Literature DB >> 4076764

[Mechanism of the refractory state of androgen hormone in Armadillidium vulgare Latr. (crustacean, isopod, oniscoid) harboring a feminizing bacteria].

P Juchault, J J Legrand.   

Abstract

In thelygenous lines of Armadillidium vulgare, neo-females and intersex males (iM) with feminizing symbiotic bacteria are not masculinized by an extract from iM androgenic gland, which, however, masculinizes bacterialess genetic females. Injection of iM hemolymph extract masculinizes these genetic females. This indicates that androgenic hormone is present in iM hemolymph. Lack of androgenic hormone activity in thelygenous lines is supposed to result from the action of bacteria on the androgenic hormone receptors. Since a temporary recovery of the male differentiation of iM can be induced by implantation of different parts of central nervous system, bacteria effect is probably indirect, through an action on a neurosecretory system, perhaps one of those controlling the functioning of the androgenic gland.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4076764     DOI: 10.1016/0016-6480(85)90082-6

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  3 in total

1.  Evidence for widespread Wolbachia infection in isopod crustaceans: molecular identification and host feminization.

Authors:  D Bouchon; T Rigaud; P Juchault
Journal:  Proc Biol Sci       Date:  1998-06-22       Impact factor: 5.349

2.  Sex and stripping: The key to the intimate relationship between Wolbachia and host?

Authors:  Ilaria Negri; Marco Pellecchia; Pierre Grève; Daniele Daffonchio; Claudio Bandi; Alberto Alma
Journal:  Commun Integr Biol       Date:  2010-03

3.  The shutting down of the insulin pathway: a developmental window for Wolbachia load and feminization.

Authors:  Benjamin Herran; Sandrine Geniez; Carine Delaunay; Maryline Raimond; Jérôme Lesobre; Joanne Bertaux; Barton Slatko; Pierre Grève
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.